SCHEMBL6049337

SCHEMBL6049337

FC(F)(F)c1cccc(OCCC(Cl)I)c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ KDM4E B2RXH2 5/20 0.46
▸ ALDH1A1 P00352 3/20 0.45
▸ GAA P10253 2/20 0.45
▸ MAOB P27338 1/20 0.45
▸ AOC3 Q16853 1/20 0.45
▸ LMNA P02545 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ LTA4H P09960 1/20 0.44
▸ PTGES O14684 1/20 0.44
▸ ALOX5 P09917 1/20 0.44
▸ PPARG P37231 1/20 0.44
▸ PPARA Q07869 1/20 0.44
▸ HRH3 Q9Y5N1 1/20 0.43
▸ MRGPRX4 Q96LA9 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6049377 0.85 MAPT (0.41) L3MBTL1KDM4EALDH1A1GAALMNA
SCHEMBL6049335 0.82 L3MBTL1 (0.39) L3MBTL1KDM4EALDH1A1GAALMNA
SCHEMBL2091560 0.79 L3MBTL1 (0.59) L3MBTL1KDM4EALDH1A1GAAMAOB
SCHEMBL9721587 0.79 L3MBTL1 (0.59) L3MBTL1KDM4EALDH1A1GAAMAOB
SCHEMBL31096458 0.79 L3MBTL1 (0.59) L3MBTL1KDM4EALDH1A1GAAMAOB
SCHEMBL6573378 0.79 L3MBTL1 (0.59) L3MBTL1KDM4EALDH1A1GAAMAOB
SCHEMBL8811646 0.79 KDM4E (0.60) L3MBTL1KDM4EALDH1A1GAAMAOB
SCHEMBL6049333 0.78 CETP (0.38) L3MBTL1PTGESALOX5PPARGPPARA
SCHEMBL2089594 0.78 L3MBTL1 (0.57) L3MBTL1KDM4EALDH1A1GAAMAOB
SCHEMBL7199882 0.78 L3MBTL1 (0.57) L3MBTL1KDM4EALDH1A1GAAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539136-A4 PPAR ALPHA SELECTIVE COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS MERCK & CO INC (US) 2006-10-18 — — EP disclosed
EP-1539136-A2 PPAR ALPHA SELECTIVE COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS Merck & Co., Inc. (US) 2005-06-15 — — EP disclosed
WO-2004010936-A2 PPAR ALPHA SELECTIVE COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS MERCK & CO., INC. (US) 2004-02-05 — — WO disclosed
Send feedback